BioSpace News Archive

Modular Devices is thrilled to announce the launch of its new website, marking a significant milestone in the company’s journey of expansion and innovation.

Alzheimer’s Community Care will host its 25th Annual Education Conference on Wednesday, May 22nd at the Marriott Palm Beach Gardens from 8-4 p.m.

Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced that it is advancing its goal to preserve capital by implementing a layoff of approximately 75% of its workforce, in addition to other cost-cutting measures.

Deep Blue Medical Advances announced today it has received the Luis Villalobos Award – Life Sciences from the Angel Capital Association (ACA), a professional association of more than 15,000 accredited angel investors and 250 angel groups, accredited platforms and family offices across North America.

Qurient Therapeutics Enters CRADA with the National Cancer Institute to Collaborate on a Phase 1/2 Clinical Study of Q901 in Combination with TROP2-ADC.

Brainomix, a pioneer in artificial intelligence (AI) imaging solutions to enable precision medicine, announced a series of new studies that were presented this week at the European Stroke Organisation Conference

iLeadBMS, a leading biotech company dedicated to the discovery and development of novel drugs for high unmet medical needs, has announced a positive outcome of IL1512, a first-in-class CXCR7 agonist, as a potential therapy for pulmonary fibrotic diseases

Alvotech and Dr. Reddy’s Laboratories today announced that the companies have entered into a license and supply agreement for the commercialization of AVT03, Alvotech’s biosimilar candidate to Prolia® and Xgeva® (denosumab).

Florida Senate President Kathleen Passidomo appointed John Couris, president and CEO of Tampa General Hospital, last month to serve as a member of the Health Care Innovation Council, a statewide volunteer organization established this year to advance innovation in health care as part of the Senate’s priority Live Healthy initiative.

The realm of cancer treatment has progressed remarkably over the preceding decennium with the advent of multiple novel treatments that involves the combinations of antibodies for the treatment of different types of cancer across the globe